Noh H, Lee JI. Current and potential therapeutic strategies for mucopolysaccharidoses. J Clin Pharm Ther 2014;39:215–24.

2. Bjoraker KJ, Delaney K, Peters C, Krivit W, Shapiro EG. Long term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation. J Dev Behav Pediatr 2006;27:290–96. [CrossRef]

3. Wraith JE. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 2005;6:489–506. [CrossRef]

4. Hinek A, Wilson SE. Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastinbinding protein and elastic fiber assembly. Am J Pathol 2000;156:925–38. [CrossRef]

5. Thomas S, Tandon S. Hurler syndrome: a case report. J Clin Pediatr Dent 2000;24:335–8. [CrossRef]

6. Ramsay MA, Savege TM, Simpson BR. Controlled sedationwith alphaxalone-alphadolone. BMJ 1974;22:656–9. [CrossRef]

7. Cortiñas-Saenz M, Martínez-Gómez L, Roncero-Goig M, SaezCuesta U, Ibarra-Martin M. Results of a major ambulatory oral surgery program using general inhalational anesthesiaon disabled patients. Med Oral Patol Oral Cir Bucal 2009;14:e605–11.

8. Guffon N, Souillet G, MaireI Straczek J, Guibaud P. Follow up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998;133:119–25. [CrossRef]

9. Kliegman RM, Behrman RE, Schor NF, St. Geme III JW and Stanton BF. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: W.B. Saunders Company;2011:480–510.

10. Herrick IA, Rhine EJ. The mucopolysaccharidoses and anaesthesia: a report of clinical experience. Can J Anaesth 1988;35:67–73. [CrossRef]

11. Walker R, Belani KG, Braunlin EA, Bruce IA, Hack H, Harmatz PR, et al. Anaesthesia and airway management in mucopolysaccharidosis 2013;36:211–9. [CrossRef]

12. John A, Fagondes S, Schwarts I. Sleep abnormalitiesin untreated patients with mucopolysaccharidosis type VI. Am J MedGenet A 2011;155A:1546–51. [CrossRef]

13. Frawley G, Fuenzalide D, Donath S. A retospective audit of anaesthetic techniques and complications in children with mucopolysaccharidosis. Pediatr Anaesth 2012;22:737–44.

14. Fleisher LA, Beckman JA, Brown KA. ACCF/AHA focused update on perioperative beta blockade incorporated in to the ACC/AHA 2007 guidelines on perioperative cardiovasculer evaluatiın and care for noncardiac surgery: a report of the American Collage of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120:e169–276. [CrossRef]

15. Bonow RO, Carabello BA, Chatterjee K. Focused update incorporated in to ACC/AHA 2006 guidelines fort he management of patients with valvular heart disaese: Society for Cardiovascular Angiography and Interventions and society of Thoracic Surgeons. Circulatıon 2008;118:e523–e661.

16. Wippermann CF, Beck M, Schranz D, Huth R, Michel-Behnke I, Jüngst BK. Mitral and aortic regurgitation in 84 patients with mucopolysaccharidoses. Eur J Pediatr 1995;154: 98–101. [CrossRef]